STAR
Live / Registered — Registered — Section 8 accepted (as of 22 Jun 2022)
What this means for you
Registered since 26 Jan 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86577513
- Registration number
- 4891860
- Mark type
- Stylized text
- Filed
- 26 Mar 2015
- Published for opposition
- 10 Nov 2015
- Registered
- 26 Jan 2016
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 001 — Chemicals: Proteins and proteins in the nature of G-protein-coupled receptors, for use in pharmaceutical research, namely, drug discovery purposes
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biopharmaceutical fields, namely, technologies related to proteins and G protein coupled receptors
Owner
- NXERA PHARMA UK LIMITED, CAMBRIDGE, GB
- Heptares Therapeutics Limited, Cambridge, GB
- Heptares Therapeutics Limited, Hertfordshire, GB
- Heptares Therapeutics Limited, Hertfordshire, GB
Prosecution history
- 26 Jan 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 24 Apr 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 22 Jun 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 22 Jun 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 22 Jun 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Jan 2022 — TEAS SECTION 8 RECEIVED
- 26 Jan 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 30 Oct 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Oct 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Jan 2016 — REGISTERED-PRINCIPAL REGISTER
- 10 Nov 2015 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Nov 2015 — PUBLISHED FOR OPPOSITION
- 21 Oct 2015 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Oct 2015 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 30 Sept 2015 — APPROVED FOR PUB - PRINCIPAL REGISTER